Publication | Open Access

Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyRefractory Follicular LymphomaEpcoritamab MonotherapyImmunotherapyOncologyRadiation OncologyCancer ResearchEpcore Nhl-1